Center for Comparative Effectiveness Research

EXPERTISE

Thomson Reuters has a large and experienced staff of researchers working with academic, government, payer, and biopharmaceutical clients on a variety of healthcare projects including those related to CER. Our researchers have a reputation for analytical work that meets the highest academic and professional standards with studies that are well published in peer-reviewed journals.

In addition to analytic expertise, Thomson Reuters has a long-standing reputation for excellence in data integration and analytic tool development for healthcare decision-making. This expertise is being brought to bear on exciting new partnership projects designed to enhance data sets, develop clinical guidelines, and make comprehensive data more readily available for CER.

As part of the Thomson Reuters Center for Comparative Effectiveness Research, staff members contribute to discussions on methodologies and issues surrounding the state-of-the-science of conducting CER. Please feel free to engage in the discussion threads to add your point-of-view.

STATE OF THE SCIENCE

	Difference-in-Difference and Instrumental Variables Approaches May Serve as an Alternative and Complement to Propensity Score Matching in Estimating Treatment Effects Zhun Cao, PhD Dr. Cao has extensive experience conducting health economic and outcomes research for pharmaceutical, biotechnology, and medical device companies. She has worked on projects in various therapeutic areas, and conducted research on statistical methodology, costs, utilization, and cost-effectiveness analysis.
	Optimizing the Value of Observational Data in Comparative Effectiveness Research (Presentation Slides) (Recorded Seminar) Tami L. Mark, PhD, MBA Dr. Mark’s expertise is in analytic data methods used in observational research. Her innovative approaches to overcoming inherent issues using observational data are helping lead the way toward improving the analytical rigor of comparative effectiveness studies. Dr. Mark is the Director of Analytic Strategies.
	Current Interest in Bayesian Statistics (Presentation Slides) (Audio Recording) Kathy Foley, PhD Dr. Foley is an innovative researcher with experience in clinical trial research, survey development, and outcomes research. She is the co-chair of the ISPOR oncology outcomes research special interest group and the Director of Strategic Consulting.
	Current Interest in Bayesian Statistics (Presentation Slides) (Audio Recording) David Smith, PhD Dr. Smith is an experienced statistician who has worked in government, pharmaceutical, and academic medical research with nearly 40 published articles. Dr. Smith was trained in the United Kingdom and has a strong interest in Bayesian statistics.